Baylor University: Study Finds Lack of Racial Diversity in Cancer Drug Clinical Trials
WACO, Texas, Aug. 17 [TNSmedicalresearch] -- Baylor University issued the following news:
New research published this week in JAMA Oncology, which includes contributions from a Baylor University undergraduate researcher, has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.
The study -- "Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018" -- was conducted by resear . . .
Terry Goodrich, 254/710-3321, Terry_Goodrich@baylor.edu
New research published this week in JAMA Oncology, which includes contributions from a Baylor University undergraduate researcher, has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.
The study -- "Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018" -- was conducted by resear . . .